HRT Black Box Warning Removed: What the FDA Change Means for Women and Who Is a Candidate

Dr. Rose traces it to the Women's Health Initiative, which ended in 2002. It enrolled 16,608 women aged 50 to 79, with a mean age of 63, most of them about 10 years past their final period, and the arm that made headlines combined a synthetic estrogen with a synthetic progestin. Per 10,000 women per year, she said, that arm saw seven more coronary events, eight more strokes, eight more pulmonary emboli and eight more cases of invasive breast cancer. She described the response as dramatic and fear-based: an emergency press conference, physicians told to take their patients off all hormone replacement therapy, and headlines that shaped how women thought about hormones for more than two decades. The warning was removed on November 10, 2025.

Dr. Rose says the arm that is not well publicized followed almost 11,000 women who had had a hysterectomy and took estrogen alone, and that group showed no increase in coronary events. Her take-home message is that where the study did show more breast cancer on hormone therapy, the key piece seems to be the synthetic progestin, not natural progesterone.

Dr. Rose says the real question is not whether hormone therapy is safe in general, but whether it is right for you at this time, given your health history, your current symptoms and your goals, and she is clear that some women are not candidates. She credits conventional visits with getting the most important part right, which is screening for contraindications such as a personal history of blood clots, stroke, breast cancer or liver disease. Where she sees them fall short is a 15-minute appointment, the same dose and route prescribed to every woman by habit, and no look at thyroid, iron, blood sugar, vitamin D, sleep or stress, any of which can drive the same symptoms.

If you have a uterus, yes. Dr. Rose explains that unopposed estrogen can build up the uterine lining and raise the risk of uterine cancer, and progesterone mitigates that. The conventional view is that a woman without a uterus does not need it, but she says progesterone is calming for most women because it boosts the neurotransmitter GABA, and when it is the right form, dosed appropriately and taken an hour before bed, sleep often improves. A minority of women have a paradoxical reaction and sleep worse or feel more anxious, and for women who tend to be sensitive to medications she often starts at half her usual dose.

Dr. Rose says yes. Testosterone is not a menopausal hormone and does not drop suddenly the way estrogen does. It declines slowly from the late 20s or early 30s, so many women first notice it in perimenopause as lost strength, less muscle definition, a low libido, brain fog and low motivation. It is not yet FDA approved for women. She says the doses she uses are low, closer to what a woman probably made at 25, so growing a beard or a deeper voice is not the outcome, and she adjusts based on goals, side effects and repeat blood work.

It varies. Dr. Rose says some women notice a difference within the first 10 days and others take two months, sometimes after the dose is raised or lowered to find the right one. Progesterone given to the right woman at the right dose often improves sleep almost immediately. She adds that hormone therapy almost always takes some tweaking of the dose or the route, which is why she repeats blood work and asks women to tell her about side effects or a lack of progress rather than waiting for an annual visit.